Literature DB >> 1220817

Hypertrichosis due to diazoxide.

J L Burton, W H Schutt, I W Caldwell.   

Abstract

Two cases of hypertrichosis due to diazoxide are described. The mechanism is unknown bu may be due either to increased cutaneous perfusion or to increased levels of cyclic AMP.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1220817     DOI： 10.1111/j.1365-2133.1975.tb05123.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


  9 in total

Review 1.  Topical minoxidil. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in alopecia areata and alopecia androgenetica.

Authors:  S P Clissold; R C Heel
Journal:  Drugs       Date:  1987-02       Impact factor: 9.546

Review 2.  Hirsutism: evaluation and management.

Authors:  R E Watson; R Bouknight; P C Alguire
Journal:  J Gen Intern Med       Date:  1995-05       Impact factor: 5.128

3.  Topical minoxidil in the treatment of alopecia areata.

Authors:  D A Fenton; J D Wilkinson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

4.  [Comparison of oral diazoxide and minoxidil in refractory hypertension].

Authors:  A Meier; P Weidmann; Z Glück; G Keusch; M Grimm; I Minder; F C Reubi
Journal:  Klin Wochenschr       Date:  1980-07-01

5.  Comparative evaluation of the new vasodilator carprazidil and minoxidil in the treatment of moderate to severe hypertension.

Authors:  M G Bianchetti; P Weidmann; K Boehringer; L Link; H Schiffl; C Beretta-Piccoli; J P Colombo
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 6.  Drug-induced hair loss and hair growth. Incidence, management and avoidance.

Authors:  A Tosi; C Misciali; B M Piraccini; A M Peluso; F Bardazzi
Journal:  Drug Saf       Date:  1994-04       Impact factor: 5.606

7.  Alopecia areata treated with tropical minoxidil.

Authors:  D A Fenton; J D Wilkinson
Journal:  J R Soc Med       Date:  1982-12       Impact factor: 18.000

8.  Minoxidil Induction of VEGF Is Mediated by Inhibition of HIF-Prolyl Hydroxylase.

Authors:  Soohwan Yum; Seongkeun Jeong; Dohoon Kim; Sunyoung Lee; Wooseong Kim; Jin-Wook Yoo; Jung-Ae Kim; Oh Sang Kwon; Dae-Duk Kim; Do Sik Min; Yunjin Jung
Journal:  Int J Mol Sci       Date:  2017-12-25       Impact factor: 5.923

9.  Possible New Strategies for the Treatment of Congenital Hyperinsulinism.

Authors:  Jelena Sikimic; Theresa Hoffmeister; Anne Gresch; Julia Kaiser; Winfried Barthlen; Carmen Wolke; Ilse Wieland; Uwe Lendeckel; Peter Krippeit-Drews; Martina Düfer; Gisela Drews
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-27       Impact factor: 5.555
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.